The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health concerns in long-term survivors with ovarian cancer: Results of Expression VI–Carolin meets HANNA–Holistic Analysis of Long-term survival with Ovarian Cancer—The international NOGGO, ENGOT and GCIG survey.
 
Hannah Woopen
No Relationships to Disclose
 
Maren Keller
No Relationships to Disclose
 
Ioana Braicu
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); Bayer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Clovis Oncology; Roche; Tesaro
 
Dario Zocholl
Travel, Accommodations, Expenses - Merck
 
Joanna Baum
No Relationships to Disclose
 
Petra Krabisch
No Relationships to Disclose
 
Tamara Boxler
No Relationships to Disclose
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Eisai; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Novartis; PharmaMar; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - Roche Pharma AG
 
Catarina Madroñal
No Relationships to Disclose
 
Marta Gil-Martin
Speakers' Bureau - AstraZeneca; MSD; PharmaMar; Roche
Travel, Accommodations, Expenses - MSD; PharmaMar; Roche
 
Vesna Bjelic-Radisic
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly; Pfizer
 
Sinisha Trpchevski
No Relationships to Disclose
 
Eleftherios Pierre Samartzis
Travel, Accommodations, Expenses - AstraZeneca
 
Viola A. Heinzelmann-Schwarz
No Relationships to Disclose
 
Patriciu Achimaș-Cadariu
No Relationships to Disclose
 
Paul Kubelac
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Novartis
 
Mehmet Ali Vardar
No Relationships to Disclose
 
Marcin Andrzej Jedryka
Honoraria - Roche
Research Funding - Sysmex (Inst)
Travel, Accommodations, Expenses - Roche
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); AstraZeneca; Carrick Therapeutics (Inst); Clovis Oncology (Inst); Deciphera (Inst); Elevar Therapeutics; Genmab (Inst); GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Mersana; MSD; Novocure; Octimet (Inst); Oncoinvent; Roche; Sotio; Tesaro (Inst); Verastem (Inst); Zentalis
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro